IN BRIEF: Faron Pharmaceuticals CEO buys shares worth €71,000
Faron Pharmaceuticals Ltd - Turku, Finland-based clinical stage biopharmaceutical company - Chief Executive Markku Jalkanen buys 25,000 shares at an average price of €2.82, worth...
Fri, 08/04/2022 - 19:30